Application of prostate health index in the diagnosis and treatment of early prostate cancer

VernacularTitle:前列腺健康指数在前列腺癌早期诊疗中的应用
Author: Xiu XU ¹ ; Yizhen SHI
Author Information

1. 苏州大学附属第二医院核医学科，苏州　215004
Keywords: Prostatic neoplasms; Health status indicators; Prostate-specific antigen; Trends
From: Chinese Journal of Nuclear Medicine and Molecular Imaging 2022;42(1):48-51
CountryChina
Language:Chinese
Abstract: Prostate cancer is one of the common diseases affecting men′s health. Early diagnosis and treatment can make a difference in greatly improving the prognosis of patients. At present, prostate specific antigen (PSA), the most widely used serum indicator in prostate cancer screening, plays an important role in improving the early diagnosis rate and reducing mortality, but the high sensitivity of PSA makes many non-prostate cancer patients receive unnecessary puncture biopsies or overtreatment. Compared with PSA, prostate health index (PHI) has higher diagnostic value. PHI can reduce unnecessary puncture biopsies, and evaluate the prognosis of patients after prostatectomy (RP), which can motivate patients to actively monitor and provide important information for clinicians to formulate the following treatment plan. This article reviews the diagnostic value of PHI in prostate cancer, the relationship with tumor volume, the combined diagnosis with other imaging tests, and the prognostic value for patients undergoing RP.